Hemoglobin-associated oxidative stress in the pericardial compartment of postoperative cardiac surgery patients

Laboratory Investigation

Volumn 95, Issue 2, 2015, Pages 132-141

  Kramer, Philip A ^a   Chacko, Balu K ^a   Ravi, Saranya ^a   Johnson, Michelle S ^a   Mitchell, Tanecia ^a   Barnes, Stephen ^a,b   Arabshahi, Alireza ^b   Dell'Italia, Louis J ^a,c,d   George, David J ^e   Steele, Chad ^f   George, James F ^a,e   Darley Usmar, Victor M ^a   Melby, Spencer J ^a,e  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d BIRMINGHAM VA MEDICAL CENTER   (United States)

^e Kentucky   (United States)

^f University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HYDROGEN PEROXIDE; ISOPROSTANE DERIVATIVE; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; SUPEROXIDE; THIOL DERIVATIVE; ANAZOLENE SODIUM; FUCHSINE;

ADULT; AORTIC VALVE REPAIR; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART SURGERY; HEART VALVE REPLACEMENT; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MALE; MITRAL VALVE REPAIR; MONOCYTE; NEUTROPHIL; OXIDATION; OXIDATIVE STRESS; PERICARDIAL EFFUSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN CARBONYLATION; RESPIRATORY BURST; SURGICAL PATIENT; ADVERSE EFFECTS; ANALYSIS OF VARIANCE; BLOOD CELL COUNT; EXTRACELLULAR FLUID; FLOW CYTOMETRY; LIPID PEROXIDATION; MASS SPECTROMETRY; METABOLISM; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PERICARDIUM; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS;

ANALYSIS OF VARIANCE; BLOOD CELL COUNT; CARDIAC SURGICAL PROCEDURES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXTRACELLULAR FLUID; F2-ISOPROSTANES; FLOW CYTOMETRY; HEMOGLOBINS; HUMANS; HYDROGEN PEROXIDE; LIPID PEROXIDATION; MASS SPECTROMETRY; NEUTROPHILS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PERICARDIUM; POSTOPERATIVE COMPLICATIONS; PROTEIN CARBONYLATION; ROSANILINE DYES; SULFHYDRYL COMPOUNDS;

EID: 84921841425     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.144     Document Type: Article

References (66)

1. Popovic JR. 1999 National Hospital Discharge Survey: annual summary with detailed diagnosis and procedure data. Vital Health Stat 2001; (151), i-v: 1-206.
2. Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996;94:390-397.
3. Parkash R, Verma A, Tang AS. Persistent atrial fibrillation: current approach and controversies. Curr Opin Cardiol 2010;25:1-7.
4. Mathew ST, Patel J, Joseph S. Atrial fibrillation: mechanistic insights and treatment options. Eur J Internal Med 2009;20:672-681.
5. Gedikli O, Dogan A, Altuntas I, et al. Inflammatory markers according to types of atrial fibrillation. Int J Cardiol 2007;120:193-197.
6. Chelazzi C, Villa G, De Gaudio AR. Postoperative atrial fibrillation. ISRN Cardiol 2011;2011:203179.
7. Aldhoon B, Melenovsky V, Peichl P, et al. New insights into mechanisms of atrial fibrillation. Physiol Res 2010;59:1-12.
8. Imazio M, Brucato A, Ferrazzi P, et al. Colchicine reduces postoperative atrial fibrillation: results of the colchicine for the prevention of the postpericardiotomy syndrome (COPPS) atrial fibrillation substudy. Circulation 2011;124:2290-2295.
9. Elahi MM, Flatman S, Matata BM. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon. Eur J Cardiovasc Prev Rehabil 2008;15:735-741.
10. Rodrigo R, Castillo R, Cereceda M, et al. Non-hypoxic preconditioning of myocardium against postoperative atrial fibrillation: mechanism based on enhancement of the antioxidant defense system. Med Hypotheses 2007;69:1242-1248.
11. Aronson D, Boulos M, Suleiman A, et al. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction. AM J Cardiol 2007;100:753-757.
12. Lappegard KT, Hovland A, Pop GA, et al. Atrial fibrillation: inflammation in disguise? Scand J Immunol 2013;78:112-119.
13. Fontes ML, Mathew JP, Rinder HM, et al. Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation. Anesth Analg 2005;101:17-23.
14. Chen MC, Chang JP, Liu WH, et al. Increased inflammatory cell infiltration in the atrial myocardium of patients with atrial fibrillation. Am J Cardiol 2008;102:861-865.
15. Ishii Y, Schuessler RB, Gaynor SL, et al. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation 2005;111:2881-2888.
16. Dudzinski DM, Mak GS, Hung JW. Pericardial diseases. Curr Prob Cardiol, 37:75-118.
17. Zipes DP. Atrial fibrillation: a review of pathophysiology. Semin Interv Cardiol 1997;2:203-213.
18. Bodson L, Bouferrache K, Vieillard-Baron A. Cardiac tamponade. Curr Opin Crit Care 2011;17:416-424.
19. Karatolios K, Pankuweit S, Maisch B. Diagnostic value of biochemical biomarkers in malignant and non-malignant pericardial effusion. Heart Failure Rev. 2013;18:337-344.
20. Ben-Horin S, Shinfeld A, Kachel E, et al. The composition of normal pericardial fluid and its implications for diagnosing pericardial effusions. Am J Med 2005;118:636-640.
21. Selmeci L, Antal M, Horkay F, et al. Enhanced accumulation of pericardial fluid ferritin in patients with coronary artery disease. Coron Artery Dis 2000;11:53-56.
22. Gibson AT, Segal MB. A study of the composition of pericardial fluid, with special reference to the probable mechanism of fluid formation. J Physiool 1978;277:367-377.
23. Eisalo A, Konttinen A. Composition of pericardial fluid in cholesterol pericarditis. Acta Med Scand 1972;191:125-128.
24. Megged O, Argaman Z, Kleid D. Purulent pericarditis in children: is pericardiotomy needed? Pediatr Emerg Care 2011;27:1185-1187.
25. Sparano DM, Ward RP. Pericarditis and pericardial effusion: management update. Curr Treat Options Cardiovasc Med 2011;13:543-555.
26. Katz LH, Pitlik S, Porat E, et al. Pericarditis as a presenting sign of infective endocarditis: two case reports and review of the literature. Scand J Infect Dis 2008;40:785-791.
27. Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet 2004;363:717-727.
28. Kramer PA, Chacko BK, Ravi S, et al. Bioenergetics and the oxidative burst: protocols for the isolation and evaluation of human leukocytes and platelets. J Vis Exp 2014;85:e51301.
29. Chacko BK, Kramer PA, Ravi S, et al. Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood. Lab Invest 2013;93:690-700.
30. Snell SM, Marini MA. A convenient spectroscopic method for the estimation of hemoglobin concentrations in cell-free solutions. J Biochem Biophys Methods 1988;17:25-33.
31. Antonini E, Brunori M. Hemoglobin and Myoglobin in their Reactions with Ligands, Amsterdam, 1971, p 436.
32. Prasain JK, Arabshahi A, Taub PR, et al. Simultaneous quantification of F2-isoprostanes and prostaglandins in human urine by liquid chromatography tandem-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2013;913-914:161-168.
33. Moore KP, Holt SG, Patel RP, et al. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem 1998;273:31731-31737.
34. Chedid P, Hurtado-Nedelec M, Marion-Gaber B, et al. Adiponectin and its globular fragment differentially modulate the oxidative burst of primary human phagocytes. Am J Pathol 2011;180:682-692.
35. Santos SS, Brunialti MK, Rigato O, et al. Generation of nitric oxide and reactive oxygen species by neutrophils and monocytes from septic patients and association with outcomes. Shock 2012;38:18-23.
36. Jukic T, Ihan A, Jukic D. Tetrahydrophthalazine derivative 'sodium nucleinate' exert its anti-inflammatory effects through inhibition of oxidative burst in human monocytes. Coll Antropol 2012;36:409-412.
37. Heyn J, Beiras-Fernandez A, Luchting B, et al. Inflammatory reactions and hydrocortisone in the setting of cardiac surgery: an overview. Cardiovasc Hematol Agents Med Chem 2011;9:56-61.
38. Fink R, Al-Obaidi M, Grewal S, et al. Monocyte activation markers during cardiopulmonary bypass. Perfusion 2003;18:83-86.
39. Franke A, Lante W, Fackeldey V, et al. Proinflammatory and antiinflammatory cytokines after cardiac operation: different cellular sources at different times. Ann Thorac Surg 2002;74:363-370, discussion 370-361.
40. Edmunds Jr. LH. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1998;66(5 Suppl):S12-S16.
41. Khare S, Bhutani LK, Rao DN. Modulation of peripheral blood derived monocytes/macrophages from leprosy patients using 'tuftsin' for production of reactive oxygen intermediates. Lepr Rev 1993;64:208-218.
42. Abdelhadi RH, Gurm HS, Van Wagoner DR, et al. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol 2004;93:1176-1178.
43. Lo B, Fijnheer R, Nierich AP, et al. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg 2005;79:1530-1535.
44. Pinho-Gomes AC, Reilly S, Brandes RP, et al. Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins. Antioxid Redox Signal 2014;20:1268-1285.
45. Guzzardi MA, Iozzo P. Fatty heart, cardiac damage, and inflammation. Rev Diabet Stud 2011;8:403-417.
46. Sacks HS, Fain JN, Cheema P, et al. Depot-specific overexpression of proinflammatory, redox, endothelial cell, and angiogenic genes in epicardial fat adjacent to severe stable coronary atherosclerosis. Metab Syndr Relat Disord 2011;9:433-439.
47. Dincic D, Jovic P, Obradovic S, et al. Lipid peroxidation intensity and lipid status parameters in the estimation of the severity of ischemic heart disease. Vojnosanitetski Pregled 1998;55:359-367.
48. Chandra M, Chandra N, Agrawal R, et al. The free radical system in ischemic heart disease. Int J Cardiol 1994;43:121-125.
49. Higdon A, Diers AR, Oh JY, et al. Cell signalling by reactive lipid species: new concepts and molecular mechanisms. Biochem J 2012;442:453-464.
50. Higdon AN, Landar A, Barnes S, et al. The electrophile responsive proteome: integrating proteomics and lipidomics with cellular function. Antioxid Redox Signal 2012;17:1580-1589.
51. Eaton P, Hearse DJ, Shattock MJ. Lipid hydroperoxide modification of proteins during myocardial ischaemia. Cardiovasc Res 2001;51:294-303.
52. Mallat Z, Philip I, Lebret M, et al. Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 1998;97:1536-1539.
53. Sovari AA, Rutledge CA, Jeong EM, et al. Mitochondria oxidative stress, connexin43 remodeling, and sudden arrhythmic death. Circ Arrhythm Electrophysiol 2013;6:623-631.
54. Karu I, Taal G, Zilmer K, et al. Inflammatory/oxidative stress during the first week after different types of cardiac surgery. Scand Cardiovasc J 2010;44:119-124.
55. McDonald CI, Fraser JF, Coombes JS, et al. Oxidative stress during extracorporeal circulation. Eur J Cardiothorac Surg 2014;46:937-943.
56. Vukasovic JL, Moraga F, Diaz-Araya G, et al. Oxidative stress in pericardial fluid and plasma and its association with ventricular function. Int J Cardiol 2005;101:197-201.
57. Maulik SK, Kumar S. Oxidative stress and cardiac hypertrophy: a review. Toxicol Mech Methods 2012;22:359-366.
58. Nguyen Dinh Cat A, Montezano AC, Burger D, et al. Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. Antioxid Redox Signal 2013;19:1110-1120.
59. Zhang M, Perino A, Ghigo A, et al. NADPH oxidases in heart failure: poachers or gamekeepers? Antioxid Redox Signal 2013;18:1024-1041.
60. Shen GX. Mitochondrial dysfunction, oxidative stress and diabetic cardiovascular disorders. Cardiovasc Hematol Disord Drug Targets 2012;12:106-112.
61. Hafstad AD, Nabeebaccus AA, Shah AM. Novel aspects of ROS signalling in heart failure. Basic Res. Cardiol. 2013;108:359.
62. Koval'chuk LV, Klebanov GI, Ribarov SR, et al. Priming of phagocytes by cytokines and water-soluble products of lipid peroxidation. Biomed Sci 1991;2:221-231.
63. Kharazmi A, Nielsen H, Rechnitzer C, et al. Interleukin 6 primes human neutrophil and monocyte oxidative burst response. Immunol Lett 1989;21:177-184.
64. Hurtado-Nedelec M, Makni-Maalej K, Gougerot-Pocidalo MA, et al. Assessment of priming of the human neutrophil respiratory burst. Methods Mol Biol 2014;1124:405-412.
65. Finkel TH, Pabst MJ, Suzuki H, et al. Priming of neutrophils and macrophages for enhanced release of superoxide anion by the calcium ionophore ionomycin. Implications for regulation of the respiratory burst. J Biol Chem 1987;262:12589-12596.
66. El-Benna J, Dang PM, Gougerot-Pocidalo MA. Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane. Semin Immunopathol 2008;30:279-289.